Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mercator Genetics Inc.

Division of Endo International PLC

Latest From Mercator Genetics Inc.

Deals Of The Week: Shire/Pervasis, Takeda/URL, Amgen/KAI

By adding Pervasis’ endothelial cell technology to the expertise it added with last year’s buyout of Advanced BioHealing, Shire is hoping to build its Regenerative Medicine unit into another powerhouse division, like its Human Genetic Therapies unit.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Endo International PLC
  • Senior Management
  • Elliott Sigal, MD, PhD, Pres. & CEO
    Nancy T Montgomery, Acting CFO
    Montgomery B Mars, VP, Bus. Dev.
    Karen J Brunke, PhD, VP of Clinical Research
  • Contact Info
  • Mercator Genetics Inc.
    Phone: (415) 617-0880
    4040 Campbell Ave.
    Menlo Park, CA 94025
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register